Baricitinib Improves Hair Regrowth in Alopecia Areata Trial
Both doses of baricitinib met the primary end point, demonstrating statistically significant improvement in scalp hair regrowth compared with placebo.
Both doses of baricitinib met the primary end point, demonstrating statistically significant improvement in scalp hair regrowth compared with placebo.
The efficacy and safety of intradermal injections of 0.5% minoxidil for the treatment of female androgenetic alopecia were evaluated in this novel study.
The demographic and clinical features of early onset androgenetic alopecia in smokers and nonsmokers was assessed.
Novel insights into lichen planus pigmentosus associated with cicatricial alopecia are provided.
A roundtable discussion by experts in issues facing patients with skin of color reveals interesting insights.
The largest study examining the relationship between alopecia areata and cardiovascular disease in a US cohort is reviewed.
Researchers analyzed real-world evidence on the safety and efficacy of dupilumab to treat atopic dermatitis.
The association of frontal fibrosing alopecia with demographic and exposition factors in a multiracial population was evaluated.
The racial and ethnic distribution of common dermatologic disorders seen at a US tertiary care center are characterized.
Men with severe hair loss were significantly more likely to test positive for COVID-19, finds study data.